Rocket Doctor AI Inc. (AIRDF) Stock Price, News, Quote & History

Oct 17, 2026
rocket-doctor-ai-inc.-(airdf)-stock-price,-news,-quote-&-history

OTC Markets OTCQB – Delayed Quote USD

0.3500 0.0000 (0.00%)

At close: October 16 at 4:00:00 p.m. EDT

  • Previous Close 0.3500
  • Open 0.3700
  • Bid 0.3373 x 1000000
  • Ask 0.3476 x 250000
  • Day’s Range 0.3500 – 0.3700
  • 52 Week Range 0.3230 – 0.7120
  • Volume 11,770
  • Avg. Volume 28,961
  • Market Cap (intraday) 35.542M
  • Beta (5Y Monthly) -0.25
  • PE Ratio (TTM) —
  • EPS (TTM) -0.2000
  • Earnings Date —
  • Forward Dividend & Yield — (0.00%)
  • Ex-Dividend Date —
  • 1y Target Est —

Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

www.treatment.com

December 31

Fiscal Year Ends

Health Information Services

Industry

Trailing total returns as of 2026-10-16, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

S&P/TSX Composite index (^GSPTSE)

13.53%

1-Year Return

S&P/TSX Composite index (^GSPTSE)

18.77%

3-Year Return

S&P/TSX Composite index (^GSPTSE)

84.38%

5-Year Return

S&P/TSX Composite index (^GSPTSE)

72.86%

View More

Valuation Measures

  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -221.31%

  • Return on Equity (ttm)

    —

  • Revenue (ttm)

    38.14k

  • Net Income Avi to Common (ttm)

    -2.01M

  • Diluted EPS (ttm)

    -0.2000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.3M

  • Total Debt/Equity (mrq)

    46.41%

  • Levered Free Cash Flow (ttm)

    -1.01M

Leave a comment